EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Intrathecal Nalbuphine Versus Other Opioids as Adjuvant to 0.5% Hyperbaric Bupivacaine in Caesarean Section: A Systematic Review and Meta-Analysis

Anna Theodorou-Kanakari iD, Styliani Karathanasi iD, Panagis M Lykoudis iD, Martina Rekatsina iD, Eleftheria Lelekaki, Maria Gavriilaki iD, Pinelopi Kouki iD

Journal of Clinical Medicine · 26.05.2026 · 15 (11) · 4108

DOI: 10.3390/jcm15114108 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.05.2026. Verfasst von Anna Theodorou-Kanakari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, General Hospital of Nikaia-Piraeus "Agios Panteleimon", 18454 Athens, Greece. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Subarachnoid anaesthesia is widely preferred for caesarean delivery due to its rapid onset, reliability, and safety. The addition of adjuvants to intrathecal hyperbaric bupivacaine has been shown to enhance the quality of anaesthesia and prolong postoperative analgesia. Opioids are among the most frequently used intrathecal adjuvants; however, their administration is associated with adverse effects. Nalbuphine, a mixed opioid agonist–antagonist, may be a promising agent for obstetric use due to its favourable pharmacodynamic properties. This study aimed to systematically review and, where feasible, meta-analyse the evidence comparing nalbuphine with other intrathecal opioid adjuvants to hyperbaric bupivacaine 0.5% for caesarean section, with a primary focus on efficacy and safety.

Methods

A systematic review and meta-analysis of controlled trials was conducted. Web of Science Core Collection, MEDLINE (PubMed), Scopus, the Library of Congress, and LISTA (EBSCO) were systematically searched to identify eligible studies. Pooled mean difference (MD) and risk ratio (RR) were calculated using random-effects model.

Results

Ten studies encompassing 1095 parturients were included. Compared with fentanyl, intrathecal nalbuphine was associated with a modest prolongation of effective analgesia. However, this finding was accompanied by substantial heterogeneity and very low certainty of evidence. In contrast, morphine provided a longer duration of analgesia than nalbuphine. Overall, nalbuphine and fentanyl demonstrated comparable block characteristics, with only minimal and clinically insignificant differences in onset and duration. Importantly, nalbuphine was associated with fewer adverse effects, particularly shivering and PONV.

Conclusions

Subarachnoid nalbuphine may serve as a potential alternative adjuvant to 0.5% hyperbaric bupivacaine in caesarean section anaesthesia. It may provide an analgesic efficacy comparable to fentanyl and, although less potent than morphine, it may demonstrate a more favourable safety profile.

Schlagwörter

Stichwörter der Autor:innen

caesarean sectionduration of effective analgesiahyperbaric bupivacaineintrathecal nalbuphinemeta-analysisopioid adjuvantsspinal anaesthesiasystematic review

Autor:innen und Institutionen

  • Department of Anaesthesiology, General Hospital of Nikaia-Piraeus "Agios Panteleimon", 18454 Athens, Greece.
  • Division of Surgery & Interventional Science, University College London (UCL), London WC1E 6BT, UK.
  • 1st Anaesthesiology Department, Aretaieion University Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.
  • Intensive Care Unit, Naval Hospital of Athens, 11521 Athina, Greece.
  • 1st Department of Neurology, AHEPA University Hospital, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

ORCID-Profile: Anna Theodorou-Kanakari, Styliani Karathanasi, Panagis M Lykoudis, Martina Rekatsina, Maria Gavriilaki, Pinelopi Kouki

Zitieren

APA

Theodorou-Kanakari, A., Karathanasi, S., Lykoudis, P. M., Rekatsina, M., Lelekaki, E., Gavriilaki, M., & Kouki, P. (2026). Intrathecal Nalbuphine Versus Other Opioids as Adjuvant to 0.5% Hyperbaric Bupivacaine in Caesarean Section: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 15(11), 4108. https://doi.org/10.3390/jcm15114108

Vancouver

Theodorou-Kanakari A, Karathanasi S, Lykoudis PM, Rekatsina M, Lelekaki E, Gavriilaki M, et al. Intrathecal Nalbuphine Versus Other Opioids as Adjuvant to 0.5% Hyperbaric Bupivacaine in Caesarean Section: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2026;15(11):4108. doi:10.3390/jcm15114108

BibTeX
@article{TheodorouKanakari2026,
  author = {Theodorou-Kanakari, Anna and Karathanasi, Styliani and Lykoudis, Panagis M and Rekatsina, Martina and Lelekaki, Eleftheria and Gavriilaki, Maria and Kouki, Pinelopi},
  title = {Intrathecal Nalbuphine Versus Other Opioids as Adjuvant to 0.5% Hyperbaric Bupivacaine in Caesarean Section: A Systematic Review and Meta-Analysis},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {4108},
  doi = {10.3390/jcm15114108}
}
Kostenlos starten →